Surge in patients increases Raffles Medical’s 3Q14 revenue by 11.1%

As healthcare insurance services also spike.

4Q is traditionally Raffles Medical Group’s strongest quarter, but this time 3Q is also bringing in solid statistics.

According to a report by OCBC Investment Research, Raffles Medical Group (RMG) reported a double-digit YoY growth in both its topline and bottomline for its 3Q14 results.

Revenue was up 11.1% YoY to S$94.5m due to a higher patient load, addition of specialist consultants and increased provision of healthcare insurance services; while PATMI jumped by 11.3% to S$15.4m.

For 9M14, revenue increased 8.6% to S$274.6m, and constituted 72.1% of our FY14 forecast. PATMI rose 9.2% to S$45.6m, or 67.1% of OCBC’s full-year projection.

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia